VC, IPOs and M&A: Central Coast could see more activity in ’24
Central Coast, Economy, Latest news, middle, Subscriber content, Technology, Tri-County EconomyThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Our view: Region’s economy has a lot to answer in 2024
Editorials, Latest news, Opinion, Subscriber contentThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind looks to clear up debt with capital from royalty agreement
Health Care & Life Science, Latest news, middle, Subscriber content, Tri-County Economy, Tri-County Public CompaniesThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Region’s top stocks look to dominate their industries
Central Coast, Latest news, left, Subscriber content, Tri-County Economy, Tri-County Public CompaniesThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind inks royalty purchase agreement for up to $200M
Central Coast, Health Care & Life Science, Latest news, Top Stories, Top StoryWestlake Village-based MannKind Corporation saw shares climb 8% on Jan. 2 after the company announced entering into a royalty purchase agreement of up to $200 million. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, sold a 1% royalty in net sales of Tyvaso DPI to Sagard Healthcare on Dec. 27. Read More →
CRE: Two multi-family apartments in Thousand Oaks sold for $171M
Columns, Latest news, Real Estate, Subscriber contentThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
